MDMA and PTSD

Exciting developments in the use of MDMA as an adjunct to talk therapy for PTSD are emerging from clinical trials. Notably, there have been no increases in suicidality linked to MDMA therapy, contrasting with placebo groups. With just a few sessions, significant reductions in PTSD symptoms have been observed, highlighting the potential of this approach when safety protocols are followed. The mental health community is eager to see further data on this promising treatment.